< Back to latest news & events

Event

IAM Live: SEP Summit

August 2024

HGF is proud to be gold sponsors of the IAM Live: SEP Summit.

The IAM Live: SEP Summit will be held at the Ironmongers’ Hall in London on the 11th-12th of September. The summit will discuss strategic insights into licensing in emerging markets, SEPs at the UPC, UK High Courts, and licensing negotiation tips and tricks.

HGF Patent Directors Dr Vincent Jennings and Nick King and HGF Partner and Patent Attorney Dr Susan Keston will be attending, and Susan will be speaking on the panel ‘Bracing for Europe’s landmark changes’. 

The panel will discuss:

  • Tactical responses to the proposed SEP regulation
  • How to alter your strategy to appease the proposal’s aims
  • Potential policy developments to keep on your radar

This event will provide an opportunity to connect with patent professionals as they share insights into how to navigate SEP licensing.

Click the button below to find out more.

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article